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Transmyocardial direct-current (DC) shock produces localized 
left ventricular myocardial necrosis without obstruction to coro-
nary blood flow. In 43 dogs sequential measurements of hemody-
namic, neuroendocrine and myocardial structural changes were 
made at baseline and for 16 weeks after DC shock. Six dogs (14%) 
died in the peri-shock period. 
By 1 week after shock, left ventricular mass, as measured by 
nuclear magnetic resonance imaging, had increased from a mean 
value ± SD of 67.9 ± 10.1 to 82.5 ± 12.9 g (p = 0.0001). Left 
ventricular end-diastolic volume was unchanged at 1 week but 
increased at 16 weeks from 56.1 ± 10.3 to 70.3 ± 10.7 ml (p = 
0.0003). Left ventricular mass demonstrated a further increase at 
12 months (107.8 ± 14.8 g). Rest cardiac output was significantly 
decreased at 4 months (3.67 ± 1.23 to 3.18 ± 0.811iters/min, p < 
0.01) as was stroke volume (43 ± 9 to 37 ± 7 ml, p :5 0.01). Left 
ventricular ejection fraction decreased progressively from 73% to 
38% at 1 year. At 4 months there were increases in mean 
pulmonary artery pressure (18 ± 4 to 23 ± 4 mm Hg, p < 0.01), 
pulmonary capillary wedge pressure (9 ± 3 to 15 ± 3 mm Hg, 
Therapeutic strategies in heart failure are evolving toward 
greater emphasis on the early phase of the natural history of 
this syndrome (1). A period of asymptomatic left ventricular 
dysfunction usually precedes overt heart failure and it has 
been proposed that interventions at this early stage may 
have an important impact on long-term prognosis (2). 
The transition from asymptomatic left ventricular dys-
function to overt congestive heart failure appears to involve 
independent pathophysiologic processes in the myocardium 
and the peripheral vasculature (3). Activation of neuroendo-
crine systems, an increase in systemic vascular resistance 
and alterations of regional blood flow are major noncardiac 
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p < 0.01) and right atrial pressure (5 ± 4 to 9 ± 3 mm Hg, p < 
0.01). 
Plasma norepinephrine was increased at 4 months (318 ± 190 
to 523 ± 221 pg/ml, p = 0.0003), whereas plasma renin activity 
was not significantly changed (4.3 ± 2.6 vs. 5.2 ± 3.4 ng/ml per 
h). Microsphere regional blood flow studies demonstrated a 50% 
reduction in skeletal muscle blood flow at 4 months (0.06 ± 
0.06 ml/min per g compared with 0.12 ± 0.09 in normal dogs, 
p = 0.05), and a reduction in the endocardial/epicardial blood 
flow ratio (1.11 ± 0.13 compared with 1.24 ± 0.13 in normal dogs, 
p = 0.02). 
Therefore, in this model of acute left ventricular damage, left 
ventricular hypertrophy precedes progressive left ventricular 
dilation. The hemodynamic and hormonal changes mimic the 
pattern observed in patients who develop left ventricular dysfunc-
tion after myocardial infarction and the model thus provides a 
unique opportunity to study physiologic and pharmacologic re-
sponses during this period. 
(JAm CoU Cardiol1992;19:460-7) 
manifestations of heart failure that may contribute to clinical 
symptoms. These manifestations do not closely correlate 
with indexes of ventricular function (4). 
The progression of ventricular dysfunction from a re-
gional wall motion abnormality after myocardial infarction to 
a globally dilated and hypocontractile left ventricle proceeds 
by as yet incompletely understood processes. Attempts to 
investigate further the progression of left ventricular dys-
function and the subsequent peripheral manifestations of 
congestive heart failure have been hampered by the lack of 
an adequate animal model. Valuable information regarding 
ventricular remodeling has been obtained from a rat model of 
myocardial infarction (5,6); however, the small size of the rat 
makes sequential analysis difficult. Attempts to create a 
large animal model have not been uniformly successful. 
Various forms of coronary artery occlusive techniques have 
generally resulted in either minor left ventricular damage or 
a high procedural mortality rate (7,8). Abnormal loading 
conditions (9,10) and cardiac toxins (11,12) have also been 
used to produce experimental heart failure, but these models 
are unpredictable and in some cases require complex sur-
gery. Furthermore, such models do not provide the oppor-
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tunity to follow the natural history of left ventricular dys-
function from a single discrete myocardial insult, a problem 
that also pertains to heart failure produced by rapid pacing 
(13). 
The canine model of chronic left ventricular dysfunction 
produced by transmyocardial direct-current (DC) shock has 
been previously described in work from this laboratory (14). 
Early experience with this model was characterized by the 
intentional production of complete heart block. It was rea-
soned that a slow heart rate would promote the development 
of congestive heart failure (15). However, the effects of 
complete heart block could not be dissociated from the 
influence of direct myocardial damage. Therefore, a modifi-
cation was developed whereby electrical damage was di-
rected to the anteroapical rather than the basal anteroseptal 
surface of the left ventricle and therefore myocardial damage 
involving 17 ± 6% (mean ± SD) of the left ventricular mass 
with a range of7% to 31% was produced without heart block 
(14). 
Preliminary experiments with this model in our labora-
tory have demonstrated systemic and regional hemodynamic 
abnormalities without evidence of overt heart failure. Ob-
servations using the digital spatial reconstructor quantitated 
a significant increase in left ventricular mass in the lst 10 
days after damage (unpublished observations). Accordingly, 
sequential nuclear magnetic resonance (NMR) imaging anal-
ysis of structural changes in the left ventricle (remodeling) 
was begun in late 1988. 
We herein report on the first long-term follow-up of this 
canine model of left ventricular dysfunction produced by 
anteroapical transmyocardial DC shock. This report pro-
vides data on all 43 dogs studied since the development of 
the nonheart block model. Specific attention is devoted to 
the analysis of changes in left ventricular structure, hemo-
dynamic measurements, neuroendocrine activation and re-
gional blood flow changes monitored throughout the course 
of this study. 
Methods 
Baseline hemodynamic and neuroendocrine studies. Forty-
three adult mongrel dogs (mean weight 20 + 2 kg) were 
studied with use of a protocol approved by the institutional 
Animal Research Committee. Dogs underwent baseline he-
modynamic measurements, NMR imaging and neuroendo-
crine studies before left ventricular damage was induced. 
Hemodynamic measurements were obtained with the dogs 
lying quietly on a surgical table, lightly sedated with mor-
phine sulfate (1 mg!kg body weight). A 7F pigtail catheter 
was placed percutaneously, under local anesthesia, into the 
thoracic aorta by way of the femoral artery. A Swan-Ganz 
catheter was placed in the pulmonary artery through the 
jugular vein. Dogs were allowed to rest quietly for 15 min 
after placement of the catheters and before baseline hemo-
dynamic and neuroendocrine measurements were obtained. 
Mean values for aortic pressure, pulmonary capillary wedge 
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pressure, pulmonary artery pressure and right atrial pressure 
were then recorded. Cardiac output was measured by the 
thermodilution technique. 
Heart rate was recorded electrocardiographically. Sys-
temic vascular resistance, pulmonary vascular resistance 
and stroke volume were calculated with standard formulas. 
An estimate of left ventricular ejection fraction was obtained 
by dividing the stroke volume (as measured by the thermodi-
lution technique) by the end-diastolic volume obtained from 
NMR imaging calculations described later. The pressures 
and cardiac output were recorded on a Hewlett-Packard 
7758B eight-channel physiologic recorder using Statham 
P23d pressure transducers and a Lexington cardiac output 
computer. Hemodynamic studies were repeated with use of 
these methods at l week (n = 13), 4 months (n = 37), 6 
months (n = 12) and l year (n = 9) after myocardial damage 
was induced. 
DC shock-induced left ventricular damage. The dogs were 
anesthetized with sodium pentobarbital, intubated and pre-
pared for the transmyocardial DC shock procedure after 
hemodynamic measurements were made. Animals were 
placed in the right lateral position. A small area of the left 
side of the chest, over the area of maximal precordial 
impulse, was shaved. The pigtail catheter was advanced 
across the aortic valve into the left ventricle. As soon as the 
catheter was across the aortic valve it was advanced 1 cm 
more to displace it from the nearby conduction tissue. A 
premeasured soft metallic guide wire was then passed 
through the catheter with 5 mm of wire extended beyond the 
catheter tip into the left ventricular cavity. One electrode 
paddle was placed on the left chest at the point of maximal 
impulse (fourth to sixth intercostal space); the second elec-
trode was connected to the proximal end of the guide wire in 
the left ventricle. It was determined through trial and error 
that moderate left ventricular damage could be produced by 
shocks of 80 J repeated at 15- to 20-s intervals. A total of 
l shock/kg body weight was administered. Heart rhythm was 
monitored by electrocardiogram (ECG) throughout the DC 
shock procedure. 
Each shock of 80 J was invariably followed by a rhythm 
disturbance. Usually this was a short run of nonsustained 
ventricular tachycardia that did not result in hemodynamic 
compromise. Rarely, cardioversion (80 J shock) was needed 
to break ventricular tachycardia when it was associated with 
low systemic blood pressure. In these situations this "ther-
apeutic" cardioversion was counted as one of the individual 
shocks for that dog. Temporary bradyarrhythmias occasion-
ally occurred but did not persist and required no therapy. A 
brief period of hypotension, occasionally associated with 
bradyarrhythmias, usually followed each individual shock. 
After the completion of the shock procedure the guide wire 
and catheter were removed and hemostasis was achieved at 
the puncture site by pressure. The procedure usually took 30 
to 45 minutes to perform. 
Measurement of left ventricular mass and volume. The 
structural response to damage induced by transmyocardial 
462 McDONALD ET AL. 
CANINE MODEL OF LEFT VENTRICULAR DYSFUNCTION 
DC shock was analyzed by sequential NMR imaging, a 
method that has been demonstrated in other laboratories 
(16,17) and in ours (18) to accurately quantitate left ventric-
ular mass and volume. A 1 tesla magnet was utilized and the 
dogs were maintained under general anesthesia during the 
imaging procedure (sodium pentobarbital). Gated short-axis 
paracoronal views of the heart were obtained with use of a 
repetition time of ::::300 ms (determined by the dog's heart 
rate). An echo time of 30 ms was used. These views were 
obtained 40 ms after the R wave of the ECG coinciding with 
end-diastole. Six slices, each 1 cm in depth with no interstice 
gap, were required to image the heart from base to apex. 
Epicardial and endocardial borders were outlined with a light 
pen. Areas were calculated with computer-assisted planim-
etry and a commercially available software package (Sie-
mens). Left ventricular mass measurement in each slice was 
calculated by subtracting the total area enclosed by the 
endocardium from that enclosed by the epicardium. The 
resultant area was multiplied by the slice depth of 1 cm to 
obtain the volume of each slice and then by 1.05 (specific 
gravity of myocardium) to calculate mass. The total left 
ventricular mass was computed by adding together the mass 
of the six slices. The left ventricular end-diastolic volume of 
each slice was represented by the area enclosed by the 
endocardium. The total left ventricular volume was com-
puted by adding the volumes of all six slices. 
NMR imaging studies were performed 1 week before the 
shock procedure (control) and at intervals after the induction 
of myocardial damage: 1 week (n = 13), 4 months (n = 19), 
6 months (n = 12) and 1 year (n = 6). Initially dogs were 
followed up for only 4 months because of difficulties in 
maintaining caged animals for a more protracted period of 
time. However, when it became apparent that useful infor-
mation may be acquired by longer follow-up, observations 
were extended to 6 months and 1 year in a small number of 
dogs. Only six of nine dogs followed up to 1 year had NMR 
imaging studies because of logistic difficulties in acquiring 
sufficient magnet time. Analysis of the T2 relaxation time 
was performed both at the baseline study and again at 1 week 
with use of a previously described technique (19). The T2 
relaxation time defines the degree of tissue fluid content and 
helps to clarify whether any observed structural change is 
due to myocardial edema (20). 
Neuroendocrine measurements. Neuroendocrine activa-
tion in this model was assessed by comparing baseline values 
for plasma norepinephrine (n = 18) and plasma renin activity 
(n = 17) with those obtained 4 months after left ventricular 
damage was induced. Arterial blood was sampled for neuro-
hormones at the time of hemodynamic assessment, before 
the administration of general anesthesia at the baseline 
study. Plasma norepinephrine was measured by a radioen-
zymatic technique. Plasma renin activity was measured by 
radioimmunoassay. 
Regional blood flow measurements. Measurements of re-
gional blood flow were made 4 months after left ventricular 
damage using an injection of microspheres 15 JLm in diame-
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ter, labeled with gamma-emitting radionuclides (3M Com-
pany) and diluted in 10% low molecular weight dextran. This 
assessment was performed in 16 of the 43 study dogs 4 
months after the shock procedure. Microspheres were mixed 
for at least 15 min in an ultrasonic bath before injections. 
Approximately 106 microspheres were injected through the 
pigtail catheter into the left ventricle. Beginning with the 
injection, a reference sample of arterial blood was with-
drawn from the aortic catheter at a constant rate of 15 mllmin 
for 90s. 
Mter completion of the microsphere injection, the ani-
mals were killed with a lethal dose of sodium pentobarbital. 
The heart was excised and fixed in 10% buffered formalin. 
After fixation, the atria and great vessels were removed from 
the heart. The ventricles were then sliced into four circum-
ferential pieces and separated into left ventricular, right 
ventricular and septal sections. The left ventricle and septum 
were subsequently transversely sliced into epicardial and 
endocardial sections. Pieces of skeletal muscle, liver, 
spleen, pancreas, renal cortex, stomach, small intestine and 
large intestine were removed and weighed. Each section 
weighed 1 to 2 g. Reference blood samples were counted in 
a Packard model 5912 gamma counting system at window 
settings corresponding to the peak energies of the radionu-
clide. The counts/min recorded in each energy window were 
corrected for background activity with a digital computer. 
Blood flow to each specimen (F) was then computed with the 
formula F = RF (Cs/RCs), where RF = reference blood flow 
(mllmin), CS = counts/min of specimen and RCs = counts/ 
min of reference blood specimen. The blood flow from each 
specimen was divided by sample weight and expressed as 
ml/min per g of tissue sample. Values obtained from the 
study animals were compared with values from a group of 
normal dogs studied in our laboratory. 
Statistical analysis. Changes in left ventricular mass, left 
ventricular volume, hemodynamic variables and left ventric-
ular ejection fraction were assessed by using multiple t tests 
comparing each time point to baseline within each variable. 
Analysis of variance (ANOV A) was not used because a 
variable number of dogs were assessed at each time period. 
Adjustments for multiple comparisons were made for each 
variable. An ANOVA was performed on a subset of nine 
dogs whose hemodynamic measurements were obtained at 
baseline and at 4 months and 1 year. A p value s0.025 was 
taken as the level of significance in this group because two 
comparisons were performed within the same set of data. A 
similar technique was used to analyze changes in left ven-
tricular mass and left ventricular volume within the subset of 
six dogs that underwent sequential NMR imaging studies 
over a period of 1 year. 
In those variables where only a baseline value and one 
follow-up value were available (plasma norepinephrine and 
plasma renin activity), paired t tests were performed to 
assess the significance of change. A nonpaired t test was 
used to compare regional blood flow because the control 
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Table 1. Hemodynamic Values (mean ± I SD) Over the 12 Month Follow-Up Period in 37 Dogs 
Baseline 1 Week 4 Months 6 Months 12 Months 
Dogs (no.) 37 13 37 12 9 
HR (beats/min) 86 ± 24 94 ± 25 88 ± 21 88 ± 18 84 ± 12 
Ao pressure (mm Hg) 101 ± 13 98 ± 16 102 ± 14 103 ± 12 101 ± 11 
CO (liters/min) 3.67 ± 1.23 3.9 ± 1.05 3.18 ± 0.81 * 3.47 ± 1.1 2.99 ± 0.48 
SV (ml/beat) 43 ± 9 42 ± 10 37 ± 7* 39 ± 7 36 ± 8* 
RAP (mm Hg) 5 ± 4 7 ± 3 9 ± 3* 12 ± 5* 8±4 
PAP(mmHg) 18 ± 4 20 ± 3 23 ± 4* 26 ± 4* 21 ± 5 
PCWP(mmHg) 9 ± 3 12 ± 3* 15 ± 3* 18 ± 4* 14 ± 5* 
PVR (dynes/s/cm5) 210 ± 74 190 ± 62 197 ± 73 197 ± 104 167 ± 35 
SVR (dynes/s/m5) 2,327 ± 7% 2,027 ± 608 2,505 ± 712 2,297 ± 779 2,514 ± 538 
*p s; 0.01 compared with baseline. Ao =aortic; CO = cardiac output; HR = heart rate; PAP = mean pulmonary artery pressure; PCWP = pulmonary capillary 
wedge pressure; PVR = pulmonary vascular resistance; SV = stroke volume; SVR = systemic vascular resistance. 
data and the 4-month follow-up data were from different 
groups of animals. Values are shown as mean values ± 1 SD. 
Results 
Forty-three dogs were studied. Eight dogs died during the 
time period reported in this study, 6 abruptly from prolonged 
refractory hypotension related to the shock procedure and 2 
unexpectedly and suddenly during the follow-up period. 
Rest hemodynamics (Table 1). Thirty-seven dogs sur-
vived the creation of left ventricular damage and were 
studied at baseline (n = 37), 1 week (n = 13), 4 months (n = 
37), 6 months (n = 12) and 1 year (n = 9) after transmyo-
cardial DC shock. 
The only significant change in hemodynamic values at 
1 week was an increase in pulmonary capillary wedge 
pressure compared with control (8 ± 3 to 12 ± 3 mm Hg, 
p = 0.01). At 4 months mean pulmonary capillary wedge 
pressure, pulmonary artery pressure and right atrial pressure 
had increased significantly from baseline whereas cardiac 
Figure 1. Continued hemodynamic deterioration in nine dogs over a 
follow-up period of 1 year, as evidenced by increasing systemic 
vascular resistance (S.V.R.) and a progressive reduction in cardiac 
output (C.O.). p values represent paired t test comparison with 
baseline. 
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output and stroke volume were significantly reduced. Heart 
rate and mean arterial pressure were unaltered. Studies 
performed at 6 months and 12 months demonstrated further 
impairment of hemodynamic performance (Table 1, Fig. 1). 
Left ventricular ejection fraction declined significantly over 
the 1-year follow-up period (Fig. 2) from a mean value of 73 
± 14% at baseline to 38 ± 4% at 1 year (p = 0.002). 
NMR imaging studies (Table 2). Nineteen dogs under-
went a baseline NMR imaging study. Follow-up studies were 
performed at 1 week (n = 13), 4 months (n = 19), 6 months 
(n = 12) and 12 months (n = 6). A prominent increase in left 
ventricular mass was seen at 1 week (67.9 ± 10.1 to 82.5 ± 
12.9 g, p = 0.0001). Left ventricular end-diastolic volume did 
not change between baseline and 1 week; however, by 4 
months left ventricular volume had increased (56.1 ± 10.3 to 
70.3 ± 10.7 ml, p = 0.0003) with a further small increment in 
left ventricular mass. A subgroup analysis of the six dogs 
that underwent NMR imaging studies at baseline and at 1 
week, 4 months, 6 months and 1 year was performed to 
determine the remodeling trends over a period of 1 year. 
Figure 3 highlights the early increase in left ventricular mass 
during the 1st week (74.5 ± 13.7 to 89.2 ± 16.5 g, p = 0.007) 
before the development of chamber dilation. Most of the 
chamber dilation occurred between 1 week and 4 months 
Figure 2. Decline in left ventricular ejection fraction over a fol-
low-up period of 1 year. *p < 0.01 compared with baseline. 
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Table 2. Values (mean± I SD) for Left Ventricular Mass (LVM) and Volume (LVV) Over a 
1-Year Follow-Up Period in 19 Dogs 
Baseline I Week 
Dogs (no.) 19 13 
LVM(g) 67.9 ± 10.1 82.5 ± 12.9* 
LVV(ml) 56.1 ± 10.3 57.2 ± 10.9 
*p :5 0.001 compared with baseline. 
(49.8 ± 6.8 to 71.2 ± 8.3 ml). There was a further increase in 
left ventricular mass between 6 and 12 months (86 ± 11.2 to 
107.8 ± 14.8 g). 
The T 2 relaxation times measured in the nondamaged 
myocardium did not increase during the 1st week after 
damage (29 ± 4 ms [baseline] vs. 27 ± 6 ms [I wk]), 
suggesting the absence of tissue edema. 
The absolute mass of damaged myocardium in each of 
the experimental dogs could not be quantitated. NMR imag-
ing slices revealed clear evidence of a thinned area in the 
anteroapical area of the left ventricle consistent with scar, 
and at the time of subsequent induced death all dogs exhib-
ited gross evidence of a thinned transmural scar. The dam-
aged area cannot be quantitated by NMR imaging, and 
subsequent scar contraction and remote hypertrophy make 
late postmortem quantitation impossible. It was nonetheless 
clear that localized myocardial necrosis was induced in all 
dogs. Quantitation of the extent of the lesion would require 
early death that would exclude long-term experiments. In 
previous studies (14) the acute lesion involved an average of 
17% of the left ventricular myocardium. 
Figure 3. Graphic display of values for left ventricular mass and 
volume in six dogs that underwent sequential nuclear magnetic 
resonance imaging studies over a follow-up period of 1 year. *p < 
0.01 compared with baseline. 
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Neuroendocrine measurements. Plasma norepinephrine 
measured in 18 dogs increased from a baseline value of 318 
± 190 pg/ml to a 4 month postshock level of 523 ± 221 pg/ml 
(p = 0.0003) (Fig. 4). Plasma renin activity was measured in 
the same cohort; there was no increase at 4 months (4.3 ± 
2.6 ng/ml per h vs. 5.2 ± 3.4 ng/ml per h) (Fig. 4). 
Regional blood flow measurement (Table 3). Regional 
blood flow analysis was performed in 16 dogs at 4 months. 
Flows obtained from the myocardium and other regional 
beds were compared with those obtained from 11 normal 
dogs studied in our laboratory. A significant reduction in the 
endocardiaVepicardial flow ratio in the myocardium was due 
primarily to a modest reduction in endocardial flow. A 
reduction in flow to the stomach and skeletal muscle bed was 
also noted. 
Discussion 
The syndrome of heart failure is characterized by abnor-
malities of both the myocardium and the periphery (3). 
Myocardial abnormalities leading to left ventricular pump 
dysfunction have previously been assumed to be linked to 
the symptoms and to the peripheral hemodynamic and 
neurohumoral abnormalities in this syndrome. Recent stud-
ies, however, have confirmed that considerable left ventric-
ular dysfunction may exist in the absence of clinical mani-
festations of heart failure (21-23). Indeed, the regional 
hemodynamic derangements of heart failure appear to occur 
late in the natural history of left ventricular dysfunction. 
Intervention at this late stage with diuretics and vasodilators 
Figure 4. Neuroendocrine measurements at baseline and 4 months 
after transmyocardial direct-current shock, *p = 0.0003. 
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Table 3. Myocardial Blood Flow Analysis (ml/g per min) at 4 
Months in Comparison With Data From Normal Dogs 
(mean± 1 SD) 
Normal 
Dogs Shock Model 
(n = 11) (n = 16) 
Epicardium 1.21 ± 0.74 1.24 ± 0.63 
Endocardium 1.55 ± 1.13 1.34 ± 0.61 
Endo/Epi ratio 1.24 ± 0.13 1.11 ± 0.13 
Right ventricle 1.07 ± 0.52 0.89 ± 0.47 
Renal cortex 5.7 ± 1.79 6.6 ± 1.85 
Skeletal muscle 0.12 ± 0.09 0.06 ± 0.06 
Liver 0.2 ± 0.25 0.22 ± 0.24 
Stomach 1.39 ± 0.93 0.84 ± 0.39 
Small intestine 0.79 ± 0.42 0.62 ± 0.2 
Large intestine 0.88 ± 0.46 0.89 ± 0.46 
Spleen 1.57 ± 0.62 1.74 ± 0.59 
Pancreas 0.92 ± 0.66 1.04 ± 0.32 
Brain 0.87 ± 0.29 1.06 ± 0.42 
Endo = endocardial; Epi = epicardial. 
p 
Value 
0.9 
0.54 
0.02 
0.34 
0.21 
0.05 
0.8 
0.04 
0.18 
0.97 
0.48 
0.53 
0.08 
may ameliorate the noncardiac manifestations of this syn-
drome but has only a modest impact on left ventricular 
volume and prognosis (24,25). In contrast, changes in myo-
cardial structure may occur early and progress silently. 
Recent clinical efforts have been directed at identifying an 
effective therapeutic strategy to alter the natural history of 
left ventricular dysfunction in the absence of symptoms of 
heart failure (2). 
Canine model of left ventricular dysfunction after myocar-
dial damage. Progress in understanding the natural history 
of left ventricular dysfunction has been hindered by the lack 
of a large animal model that closely mimics the human 
condition of left ventricular dysfunction after myocardial 
damage. Several methods have been utilized in an attempt to 
produce such a model, but these have not been particularly 
successful. For example, a canine model of myocardial 
infarction has generally resulted in either too little damage, 
because of extensive coronary collateral supply, or alterna-
tively too extensive damage leading to rapid demise (7 ,8). 
Furthermore, perinfarction ischemia may variably contrib-
ute to ventricular dysfunction. Myocardial damage from 
toxins results in a diffuse cardiomyopathy that does not 
afford the opportunity to study the natural history of struc-
tural changes occurring after discrete myocardial necrosis 
(11,12). The model described herein allows for the study of 
the natural history of both the cardiac and the peripheral 
manifestations of left ventricular dysfunction as it develops 
from a discrete myocardial lesion. 
The use of transmyocardial DC shock to induce left 
ventricular dysfunction was described in a report from this 
laboratory in 1978 (14). This method results in the induction 
of transmural myocardial necrosis involving on average 17% 
of the left ventricular myocardium (14). Hematoxylin-eosin-
stained sections of the acute electrical myocardial injury 
revealed evidence of interstitial edema, hemorrhage from 
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ruptured capillaries and banded sarcoplasmic alterations of 
the myocytes. The procedural mortality rate was 14%. 
Six dogs in the current series died during the DC shock 
procedure. In each case death was due to refractory hypo-
tension. Echocardiography performed during attempted re-
suscitation in these six dogs showed extensive wall motion 
abnormalities extending beyond the anteroapical area of the 
left ventricle, which is the usual site of damage. It is possible 
that these animals were unusually sensitive to the electrical 
shock and consequently may have incurred more extensive 
damage. It is also possible that the electrical injury induced 
a "stunning" effect, not only in myocardium destined to 
become necrotic, but also in distant remote myocardium. 
However, we have performed echocardiography in other 
dogs immediately after the procedure and have noted that 
the remote myocardium functions well. 
Follow-up studies of model of left ventricular dysfunction. 
The long-term follow-up of this model suggests that trans-
myocardial DC shock is a reproducible means of causing left 
ventricular damage of sufficient degree to result in substan-
tial ventricular dysfunction. Moreover, this model appears 
to mimic very closely the syndrome of asymptomatic or 
mildly symptomatic left ventricular dysfunction in humans 
after myocardial infarction (21-23). There is evidence of 
significant hemodynamic abnormalities 4 months after dam-
age with elevated filling pressures and reduced cardiac 
output. Sequential analysis of left ventricular ejection frac-
tion shows continued deterioration in ventricular function 
over the follow-up period (Fig. 2). Although the majority of 
dogs were followed up for only 4 months, nine dogs under-
went hemodynamic follow-up for 1 year. The trends in 
cardiac output and systemic vascular resistance seen in 
these nine dogs suggest continued hemodynamic deteriora-
tion over this extended period (Fig. 1). Sudden death was 
observed in two dogs during the follow-up period. More 
prolonged follow-up, currently being carried out, may iden-
tify the development of overt, symptomatic heart failure. 
The sympathetic nervous system is activated in this 
model, as indicated by the elevated plasma norepinephrine 
levels at 4 months compared with baseline values (318 ± 190 
to 523 ± 221 pg/ml, p = 0.0003). In contrast, plasma renin 
activity was not increased at 4 months. These neuroendo-
crine changes are very similar to those occurring in asymp-
tomatic left ventricular dysfunction in humans, again under-
lining the similarity of this model to that condition (23). 
Ventricular remodeling after myocardial damage: compar-
ison with myocardial infarction. Changes in myocardial 
structure were characterized by an early increase in left 
ventricular mass with subsequent chamber dilation. While 
NMR imaging provides a very accurate assessment of left 
ventricular mass and volume (16-18), it does not define the 
nature of the tissue involved in this response. The marked 
increase in mass occurring l week after myocardial damage 
raises the possibility that edema formation could account for 
some of the increase in left ventricular weight. However, the 
absence of prolongation of the T 2 relaxation time argues 
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against a significant accumulation of inflammatory fluid or 
edema in the uninvolved myocardium (20) where the mass 
was visibly increased. 
Ventricular remodeling has previously been character-
ized by initial chamber dilation with a subsequent increase in 
mass , the latter occurring presumably as a means of reduc-
ing wall stress (26). The structural changes noted in the DC 
shock model indicate that mass increase occurs before 
dilation. This apparent difference regarding the sequence of 
structural change occurring after myocardial damage may 
reflect differences in the extent of myocardial necrosis. Very 
large areas of necrosis predispose to myocardial infarct 
expansion, a factor that undoubtedly explains a significant 
amount of the early chamber dilation seen after a large 
myocardial infarctions (26-28). Moreover, infarct expansion 
predisposes the myocardium to further dilation involving the 
noninfarcted segments (29). This "secondary dilation" has 
been documented as early as 2 weeks after myocardial 
damage and may contribute to the early increase in chamber 
size (30). In the DC shock model the degree of damage is 
only moderate, which may make expansion of the necrotic 
zone less likely to occur. Furthermore, blood flow to the 
damaged area is unlikely to be compromised in this model, 
as the epicardial vessel supplying the necrotic zone remains 
patent. It has recently been suggested (31) that a patent 
infarct-related vessel may protect the damaged area from 
expansion ("open artery hypothesis"). For these reasons, 
expansion of the necrotic zone may not occur in the DC 
shock model, thus reducing the likelihood of early chamber 
dilation. 
The stimulus for this documented increase in ventricular 
mass is unknown, since the only hemodynamic abnormality 
at I week was a slight increase in pulmonary capillary wedge 
pressure at a time that left ventricular mass had increased by 
22%. A similar increase in ventricular mass without the 
stimulus of progressive chamber dilation has been described 
(32) in humans after myocardial infarction, thus suggesting 
that this response is not species or model dependent. 
Regional blood flow. Regional blood flow analysis at 4 
months revealed a reduction in the endocardiaVepicardial 
blood flow ratio in the myocardium. This decrease reflects a 
reduction in endocardial blood flow and is in agreement with 
previous work on regional blood flow in myocardial hyper-
trophy after infarction (33). Reduced endocardial blood flow 
may result from the compressive force on the endocardium 
of the elevated ventricular diastolic pressure, or may be due 
to a relative impairment in growth of the coronary vascula-
ture as left ventricular mass increases. Such a phenomenon 
has been described in other clinical settings where ventric-
ular hypertrophy occurs, and it may render the myocardium 
more susceptible to ischemic injury (34). Further abnormal-
ities in regional hemodynamics also were observed in this 
model. There was a significant reduction in skeletal muscle 
flow as noted previously in both experimental and clinical 
heart failure (35,36), and splanchnic blood flow also tended 
to be reduced. These findings suggest that alterations in 
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peripheral hemodynamics may occur before overt heart 
failure develops. Conversely, rest renal cortical blood flow 
was maintained during the early phase of left ventricular 
dysfunction in this model. This is in keeping with the original 
observations of Merrill (37), who documented that renal 
plasma flow and glomerular filtration rate were often normal 
at rest in patients with mild heart failure. However, mild 
exercise may result in a significant reduction in renal flow 
(38). 
Advantages and limitations of the animal model. This 
model possesses many distinct advantages over alternative 
models of left ventricular damage. The creation of the model 
is relatively noninvasive and has a low procedural mortality. 
The area of necrosis produced is discrete and free of ongoing 
ischemia. Sequential observations suggest that this model 
mimics the syndrome of left ventricular dysfunction occur-
ring after myocardial infarction in humans, particularly the 
structural and neuroendocrine changes (21-23). However, 
three limitations should be noted. First, the histologic ap-
pearance of the damaged tissue differs from the coagulative 
necrosis seen after myocardial infarction. Transmyocardial 
DC shock produces myocardial necrosis characterized by 
contraction bands, interstitial hemorrhage and edema (14). 
The significance of the histologic disparity between this 
injury and coagulation necrosis is unknown. A second 
limitation of the model is the difficulty in defining the exact 
degree of damage produced by transmyocardial DC shock in 
each dog. Data from this laboratory from animals killed at 
24 h have previously demonstrated that this procedure 
results in damage to an average 17% of the left ventricular 
myocardium (range 7% to 31%) (14). This moderate variabil-
ity in damage may not be of major importance especially 
with regard to structural remodeling of the ventricle. Finally, 
morphometric analysis of the myocardial tissue has not been 
performed. Consequently, it remains unclear whether the 
documented increase in mass represents predominant myo-
cyte hypertrophy or alteration of nonmyocyte cardiac tissue 
such as fibroblasts and collagen. 
Conclusions. A canine model of left ventricular dysfunc-
tion produced by transmyocardial DC shock provides a 
reproducible model of progressive left ventricular dysfunc-
tion resulting from a single discrete lesion. This model 
should lend itself to studies of mechanisms of myocardial 
remodeling, of the relation between cardiac and peripheral 
adaptations to left ventricular dysfunction and of the re-
sponse to physiologic and pharmacologic interventions. 
We gratefully acknowledge the statistical advice ofTom Rector, PhD and the 
secretarial assistance of Andrea Dahl, Julie Anderson and Kathy Wheeler in 
the preparation of the manuscript. 
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